alexa Induction Chemotherapy Followed by Concomitant Chemorad
ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Induction Chemotherapy Followed by Concomitant Chemoradiation in Head and Neck Squamous Cell Carcinoma: A Single Institution Experience

Guila Delouya1*, Sébastien Clavel1, Nancy El-Bared1, Denis Soulières2, Bernard Fortin1, Danielle Charpentier2, Edith Filion1, David Donath1, Philippe Després1, Louis Guertin3 and Phuc Felix Nguyen-Tan1

1Department of Radiation Oncology, Centre hospitalier de l’Université de Montréal (CHUM), Hôpital Notre-Dame, Montréal, Québec, Canada

2Department of Medical Oncology, Centre hospitalier de l’Université de Montréal (CHUM), Hôpital Notre-Dame, Montréal, Québec, Canada

3Department of otolaryngology, Centre hospitalier de l’Université de Montréal (CHUM), Hôpital Notre-Dame, Montréal, Québec, Canada

Corresponding Author:
Dr. Guila Delouya
Centre hospitalier de l’Université de Montréal (CHUM)
Hôpital Notre-Dame, Department of Radiation Oncology
1560 Sherbrooke St. E., Montréal
Québec, H2L 4M1, Canada
Tel: (514) 890-8254
Fax: (514) 412-7537
E-mail: [email protected]

Received date: June 14, 2011; Accepted date: November 16, 2011; Published date: November 21, 2011

Citation: Delouya G, Clavel S, El-Bared N, Soulières D, Fortin B, et al. (2012) Induction Chemotherapy Followed by Concomitant Chemoradiation in Head and Neck Squamous Cell Carcinoma: A Single Institution Experience. Otolaryngol 1:108. doi:10.4172/2161-119X.1000108

Copyright: © 2012 Delouya G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Objective: Phase 3 studies are underway to compare induction chemotherapy (IC) followed by concomitant chemoradiation (CRT) with CRT alone in advanced head and neck cancer. The purpose is to report the outcome of patients with advanced head and neck cancer treated at Centre Hospitalier de l’Université de Montréal (CHUM) with IC followed by CRT.

Methods: From March 1998 to December 2007, 56 consecutive patients were treated for advanced squamous cell carcinoma of the head and neck with high-dose IC followed by CRT. Sixteen patients with carcinoma of the nasopharynx, paranasal sinuses or nasal cavity were excluded. Patients presented with either T4 (60%) or N3 (60%) disease. Outcomes were computed using Kaplan-Meier curves. The number of IC cycles were compared with logrank tests.

Results: The 2 year estimates of OS, DFS, LRC and DMFS rates were 58%, 46%, 78% and 75% respectively. At last follow-up, we observed 17 patients with relapse of which 10 were at a distant site. When stratified by the number of IC cycles, a DMFS rate of 87% was observed for 1-2 cycles vs 49% for 3 cycles, p=0.05.

Conclusions: Despite intensive treatment with platinum based IC and CRT, prognosis for this highly advanced population of T4 or N3 cancers is poor. The number of IC cycles seem to influence the rate of DM. Further trials are needed to answer the question regarding IC followed by CRT vs CRT alone. Targeted therapies might also yield more promising results.

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords